The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Sanofi

Immune checkpoint inhibitors (ICI) response in metastatic non-small cell lung cancer (NSCLC) patients with WNT pathway mutations (APC/CTNNB1).
 
Patricia Iranzo
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Kyowa Hakko Kirin; Merck Sharp & Dohme; MSD Oncology; Roche
Travel, Accommodations, Expenses - Acraf; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Ana Callejo
Consulting or Advisory Role - Boehringer Ingelheim; Kyowa Hakko Kirin; Lilly; MSD Oncology; Roche Pharma AG; Sanofi
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Kyowa Hakko Kirin; MSD Oncology; Pfizer; Roche Pharma AG
 
Anna Pedrola
No Relationships to Disclose
 
Nuria Pardo Aranda
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD Oncology; Pfizer; Roche
 
Alejandro Navarro
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche
Expert Testimony - Oryzon Genomics
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer
 
Alex Martinez-Marti
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; MSD Oncology; Pfizer; Roche
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Susana Cedres Perez
Consulting or Advisory Role - Amphera; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer/EMD Serono; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Javier Ros
No Relationships to Disclose
 
Juan David Assaf
No Relationships to Disclose
 
Nadia Saoudi
No Relationships to Disclose
 
Caterina Carbonell
Research Funding - Merck
 
Ramon Amat
No Relationships to Disclose
 
Joan Frigola
No Relationships to Disclose
 
Jose Jimenez
No Relationships to Disclose
 
Rodrigo Dienstmann
Consulting or Advisory Role - Roche
Speakers' Bureau - Amgen; Ipsen; MSD Oncology; Roche; Sanofi; SERVIER; Symphogen
Research Funding - Merck
 
Hector G. Palmer
Research Funding - Bayer; BluPrint Oncology; Cellestia Biotech; Merus; Novartis
 
Ana Vivancos
Consulting or Advisory Role - Bayer Health; Guardant Health; Novartis
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; AstraZeneca; BerGenBio; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Guardant Health; Janssen; Lilly; Medscape; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; priME Oncology; Roche; Samsung; Takeda; touchIME
Speakers' Bureau - AbbVie; Abbvie; AstraZeneca; BerGenBio; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Guardant Health; Janssen; Lilly; medscape; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Prime Oncology; Roche; Samsung; Takeda; touchIME
Research Funding - EMD Serono (Inst); Merck (Inst)
Other Relationship - GRÍFOLS